Share Email Print
cover

Proceedings Paper • new

Assessment of wavelengths with skin tones for an implantable FRET-based glucose biosensor
Author(s): Lydia E. Colvin; Ping Dong; A. Kristen Means; Melissa A. Grunlan; Gerard L. Coté
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Diabetes management is reliant on consistent and accurate monitoring. Low patient compliance for the standard finger prick test along with its intermittent nature may lead to undetected highs and lows. In 2014, poor glycemic control caused 207,000 hospitalizations from hyperglycemia and 245,000 hospitalizations from hypoglycemia in the US. The implementation of continuous glucose monitors (CGMs) can provide a more thorough illustration of blood glucose level fluctuations. Currently, there are several transcutaneous CGMs produced by Abbott, Dexcom, and Medtronic along with a fully implantable option by Eversense. Improvements to both the sensitivity and size of CGMs are being studied by our group through the development of a competitive binding, FRET-based, glucose biosensor that is fully implantable and probed optically with an external “watch-type” device. In previous work, our group has successfully developed an assay, but due to the near-UV excitation wavelength range, there are limitations in decreased skin penetration depth along with excess noise due to autofluorescence of the tissue. In this work, we investigated the FRET response through skin samples of both Blue (APTS) and near infrared (NIR) (Alexa Fluor 700 and 750) dyes. These dye samples were encapsulated within previously reported hollow, cylindrical, thermoresponsive hydrogel membranes and the fluorescence intensity signals were compared when placed beneath thin and thick (0.87 and 1.85 mm) rat skin samples. The FRET response of AF-700 and AF-700 was measured when placed beneath thicker skin samples of both lighter and dark pigmentations. The results indicate that the use of NIR dyes is needed to allow for a reasonable implantation depth for the implantable biosensor.

Paper Details

Date Published: 20 February 2019
PDF: 7 pages
Proc. SPIE 10885, Optical Diagnostics and Sensing XIX: Toward Point-of-Care Diagnostics, 108850Y (20 February 2019); doi: 10.1117/12.2509912
Show Author Affiliations
Lydia E. Colvin, Texas A&M Univ. (United States)
Ping Dong, Texas A&M Univ. (United States)
A. Kristen Means, Texas A&M Univ. (United States)
Melissa A. Grunlan, Texas A&M Univ. (United States)
Gerard L. Coté, Texas A&M Univ. (United States)


Published in SPIE Proceedings Vol. 10885:
Optical Diagnostics and Sensing XIX: Toward Point-of-Care Diagnostics
Gerard L. Coté, Editor(s)

© SPIE. Terms of Use
Back to Top